| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $54K | +0.0% |
| SG&A Expense | $961K | +8.1% |
| Operating Income | -$961K | -1.9% |
| Net Income | -$1.6M | -4.5% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1K | -95.4% |
| Current Assets | $1K | -95.9% |
| Total Assets | $1K | -95.9% |
| Current Liabilities | $12.0M | +11.8% |
| Stockholders' Equity | -$12.0M | -12.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$303K | +39.1% |
| Financing Cash Flow | $279K | -39.4% |